The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Personalized Medicines-Global Market Insights and Sales Trends 2025
Synopsis
Personalized medicine is tailoring of a treatment to a specific patient i.e. designing medicine treatment on the basis of diagnosis, disease condition, patient history, body physics, and other factors related to patients and diseases. Personalized medicine is also known as precision medicine, stratified medicine, or P4 medicine.
The global Personalized Medicines market size is expected to reach US$ 540120 million by 2029, growing at a CAGR of 10.9% from 2023 to 2029. The market is mainly driven by the significant applications of Personalized Medicines in various end use industries. The expanding demands from the Hospitals Pharmacies, Retail Pharmacies, Dietary Care Centers and Others, are propelling Personalized Medicines market. PM Diagnostics, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the PM Therapeutics segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Personalized Medicines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Personalized Medicines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Personalized Medicines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Personalized Medicines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Personalized Medicines covered in this report include 3G Biotech, Quest Diagnostics, Laboratory Corporation of America, Abbott, Agendia NV, Asuragen Inc, Becton Dickinson, CardioDx Inc. and Foundation Medicine, etc.
The global Personalized Medicines market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
3G Biotech
Quest Diagnostics
Laboratory Corporation of America
Abbott
Agendia NV
Asuragen Inc
Becton Dickinson
CardioDx Inc.
Foundation Medicine
Qiagen
Siemens Healthcare
Amgen
Bristol-Myers Squibb
GE Healthcare
Pfizer
Sanofi
23andMe
Illumina
Global Personalized Medicines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Personalized Medicines market, Segment by Type:
PM Diagnostics
PM Therapeutics
Personalized Medical Care
Personalized Nutrition & Wellness
Global Personalized Medicines market, by Application
Hospitals Pharmacies
Retail Pharmacies
Dietary Care Centers
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Personalized Medicines companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Personalized medicine is tailoring of a treatment to a specific patient i.e. designing medicine treatment on the basis of diagnosis, disease condition, patient history, body physics, and other factors related to patients and diseases. Personalized medicine is also known as precision medicine, stratified medicine, or P4 medicine.
The global Personalized Medicines market size is expected to reach US$ 540120 million by 2029, growing at a CAGR of 10.9% from 2023 to 2029. The market is mainly driven by the significant applications of Personalized Medicines in various end use industries. The expanding demands from the Hospitals Pharmacies, Retail Pharmacies, Dietary Care Centers and Others, are propelling Personalized Medicines market. PM Diagnostics, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the PM Therapeutics segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Personalized Medicines, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Personalized Medicines market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Personalized Medicines market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Personalized Medicines sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Personalized Medicines covered in this report include 3G Biotech, Quest Diagnostics, Laboratory Corporation of America, Abbott, Agendia NV, Asuragen Inc, Becton Dickinson, CardioDx Inc. and Foundation Medicine, etc.
The global Personalized Medicines market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
3G Biotech
Quest Diagnostics
Laboratory Corporation of America
Abbott
Agendia NV
Asuragen Inc
Becton Dickinson
CardioDx Inc.
Foundation Medicine
Qiagen
Siemens Healthcare
Amgen
Bristol-Myers Squibb
GE Healthcare
Pfizer
Sanofi
23andMe
Illumina
Global Personalized Medicines market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Personalized Medicines market, Segment by Type:
PM Diagnostics
PM Therapeutics
Personalized Medical Care
Personalized Nutrition & Wellness
Global Personalized Medicines market, by Application
Hospitals Pharmacies
Retail Pharmacies
Dietary Care Centers
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Personalized Medicines companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Personalized Medicines
1.1 Personalized Medicines Market Overview
1.1.1 Personalized Medicines Product Scope
1.1.2 Personalized Medicines Market Status and Outlook
1.2 Global Personalized Medicines Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Personalized Medicines Market Size by Region (2018-2029)
1.4 Global Personalized Medicines Historic Market Size by Region (2018-2023)
1.5 Global Personalized Medicines Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Personalized Medicines Market Size (2018-2029)
1.6.1 North America Personalized Medicines Market Size (2018-2029)
1.6.2 Europe Personalized Medicines Market Size (2018-2029)
1.6.3 Asia-Pacific Personalized Medicines Market Size (2018-2029)
1.6.4 Latin America Personalized Medicines Market Size (2018-2029)
1.6.5 Middle East & Africa Personalized Medicines Market Size (2018-2029)
2 Personalized Medicines Market by Type
2.1 Introduction
2.1.1 PM Diagnostics
2.1.2 PM Therapeutics
2.1.3 Personalized Medical Care
2.1.4 Personalized Nutrition & Wellness
2.2 Global Personalized Medicines Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Personalized Medicines Historic Market Size by Type (2018-2023)
2.2.2 Global Personalized Medicines Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Personalized Medicines Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Personalized Medicines Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Personalized Medicines Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Personalized Medicines Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Personalized Medicines Revenue Breakdown by Type (2018-2029)
3 Personalized Medicines Market Overview by Application
3.1 Introduction
3.1.1 Hospitals Pharmacies
3.1.2 Retail Pharmacies
3.1.3 Dietary Care Centers
3.1.4 Others
3.2 Global Personalized Medicines Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Personalized Medicines Historic Market Size by Application (2018-2023)
3.2.2 Global Personalized Medicines Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Personalized Medicines Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Personalized Medicines Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Personalized Medicines Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Personalized Medicines Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Personalized Medicines Revenue Breakdown by Application (2018-2029)
4 Personalized Medicines Competition Analysis by Players
4.1 Global Personalized Medicines Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Personalized Medicines as of 2022)
4.3 Date of Key Players Enter into Personalized Medicines Market
4.4 Global Top Players Personalized Medicines Headquarters and Area Served
4.5 Key Players Personalized Medicines Product Solution and Service
4.6 Competitive Status
4.6.1 Personalized Medicines Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 3G Biotech
5.1.1 3G Biotech Profile
5.1.2 3G Biotech Main Business
5.1.3 3G Biotech Personalized Medicines Products, Services and Solutions
5.1.4 3G Biotech Personalized Medicines Revenue (US$ Million) & (2018-2023)
5.1.5 3G Biotech Recent Developments
5.2 Quest Diagnostics
5.2.1 Quest Diagnostics Profile
5.2.2 Quest Diagnostics Main Business
5.2.3 Quest Diagnostics Personalized Medicines Products, Services and Solutions
5.2.4 Quest Diagnostics Personalized Medicines Revenue (US$ Million) & (2018-2023)
5.2.5 Quest Diagnostics Recent Developments
5.3 Laboratory Corporation of America
5.3.1 Laboratory Corporation of America Profile
5.3.2 Laboratory Corporation of America Main Business
5.3.3 Laboratory Corporation of America Personalized Medicines Products, Services and Solutions
5.3.4 Laboratory Corporation of America Personalized Medicines Revenue (US$ Million) & (2018-2023)
5.3.5 Abbott Recent Developments
5.4 Abbott
5.4.1 Abbott Profile
5.4.2 Abbott Main Business
5.4.3 Abbott Personalized Medicines Products, Services and Solutions
5.4.4 Abbott Personalized Medicines Revenue (US$ Million) & (2018-2023)
5.4.5 Abbott Recent Developments
5.5 Agendia NV
5.5.1 Agendia NV Profile
5.5.2 Agendia NV Main Business
5.5.3 Agendia NV Personalized Medicines Products, Services and Solutions
5.5.4 Agendia NV Personalized Medicines Revenue (US$ Million) & (2018-2023)
5.5.5 Agendia NV Recent Developments
5.6 Asuragen Inc
5.6.1 Asuragen Inc Profile
5.6.2 Asuragen Inc Main Business
5.6.3 Asuragen Inc Personalized Medicines Products, Services and Solutions
5.6.4 Asuragen Inc Personalized Medicines Revenue (US$ Million) & (2018-2023)
5.6.5 Asuragen Inc Recent Developments
5.7 Becton Dickinson
5.7.1 Becton Dickinson Profile
5.7.2 Becton Dickinson Main Business
5.7.3 Becton Dickinson Personalized Medicines Products, Services and Solutions
5.7.4 Becton Dickinson Personalized Medicines Revenue (US$ Million) & (2018-2023)
5.7.5 Becton Dickinson Recent Developments
5.8 CardioDx Inc.
5.8.1 CardioDx Inc. Profile
5.8.2 CardioDx Inc. Main Business
5.8.3 CardioDx Inc. Personalized Medicines Products, Services and Solutions
5.8.4 CardioDx Inc. Personalized Medicines Revenue (US$ Million) & (2018-2023)
5.8.5 CardioDx Inc. Recent Developments
5.9 Foundation Medicine
5.9.1 Foundation Medicine Profile
5.9.2 Foundation Medicine Main Business
5.9.3 Foundation Medicine Personalized Medicines Products, Services and Solutions
5.9.4 Foundation Medicine Personalized Medicines Revenue (US$ Million) & (2018-2023)
5.9.5 Foundation Medicine Recent Developments
5.10 Qiagen
5.10.1 Qiagen Profile
5.10.2 Qiagen Main Business
5.10.3 Qiagen Personalized Medicines Products, Services and Solutions
5.10.4 Qiagen Personalized Medicines Revenue (US$ Million) & (2018-2023)
5.10.5 Qiagen Recent Developments
5.11 Siemens Healthcare
5.11.1 Siemens Healthcare Profile
5.11.2 Siemens Healthcare Main Business
5.11.3 Siemens Healthcare Personalized Medicines Products, Services and Solutions
5.11.4 Siemens Healthcare Personalized Medicines Revenue (US$ Million) & (2018-2023)
5.11.5 Siemens Healthcare Recent Developments
5.12 Amgen
5.12.1 Amgen Profile
5.12.2 Amgen Main Business
5.12.3 Amgen Personalized Medicines Products, Services and Solutions
5.12.4 Amgen Personalized Medicines Revenue (US$ Million) & (2018-2023)
5.12.5 Amgen Recent Developments
5.13 Bristol-Myers Squibb
5.13.1 Bristol-Myers Squibb Profile
5.13.2 Bristol-Myers Squibb Main Business
5.13.3 Bristol-Myers Squibb Personalized Medicines Products, Services and Solutions
5.13.4 Bristol-Myers Squibb Personalized Medicines Revenue (US$ Million) & (2018-2023)
5.13.5 Bristol-Myers Squibb Recent Developments
5.14 GE Healthcare
5.14.1 GE Healthcare Profile
5.14.2 GE Healthcare Main Business
5.14.3 GE Healthcare Personalized Medicines Products, Services and Solutions
5.14.4 GE Healthcare Personalized Medicines Revenue (US$ Million) & (2018-2023)
5.14.5 GE Healthcare Recent Developments
5.15 Pfizer
5.15.1 Pfizer Profile
5.15.2 Pfizer Main Business
5.15.3 Pfizer Personalized Medicines Products, Services and Solutions
5.15.4 Pfizer Personalized Medicines Revenue (US$ Million) & (2018-2023)
5.15.5 Pfizer Recent Developments
5.16 Sanofi
5.16.1 Sanofi Profile
5.16.2 Sanofi Main Business
5.16.3 Sanofi Personalized Medicines Products, Services and Solutions
5.16.4 Sanofi Personalized Medicines Revenue (US$ Million) & (2018-2023)
5.16.5 Sanofi Recent Developments
5.17 23andMe
5.17.1 23andMe Profile
5.17.2 23andMe Main Business
5.17.3 23andMe Personalized Medicines Products, Services and Solutions
5.17.4 23andMe Personalized Medicines Revenue (US$ Million) & (2018-2023)
5.17.5 23andMe Recent Developments
5.18 Illumina
5.18.1 Illumina Profile
5.18.2 Illumina Main Business
5.18.3 Illumina Personalized Medicines Products, Services and Solutions
5.18.4 Illumina Personalized Medicines Revenue (US$ Million) & (2018-2023)
5.18.5 Illumina Recent Developments
6 North America
6.1 North America Personalized Medicines Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Personalized Medicines Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Personalized Medicines Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Personalized Medicines Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Personalized Medicines Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Personalized Medicines Market Dynamics
11.1 Personalized Medicines Industry Trends
11.2 Personalized Medicines Market Drivers
11.3 Personalized Medicines Market Challenges
11.4 Personalized Medicines Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
